I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 4 studies | 18% ± 3% | |
| epithelial cell | 3 studies | 29% ± 1% | |
| endothelial cell | 3 studies | 21% ± 3% | |
| fibroblast | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 4 studies | 18% ± 3% | |
| epithelial cell | 3 studies | 29% ± 1% | |
| endothelial cell | 3 studies | 21% ± 3% | |
| fibroblast | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 1454.86 | 180 / 180 | 100% | 13.38 | 430 / 430 |
| prostate | 100% | 1097.47 | 245 / 245 | 100% | 17.97 | 502 / 502 |
| brain | 100% | 1400.10 | 2641 / 2642 | 100% | 26.33 | 705 / 705 |
| breast | 100% | 1134.22 | 459 / 459 | 100% | 21.30 | 1117 / 1118 |
| lung | 100% | 1087.02 | 577 / 578 | 100% | 16.48 | 1155 / 1155 |
| uterus | 100% | 1229.39 | 170 / 170 | 100% | 13.49 | 458 / 459 |
| esophagus | 100% | 937.63 | 1439 / 1445 | 100% | 13.11 | 183 / 183 |
| thymus | 100% | 1235.50 | 653 / 653 | 100% | 18.26 | 602 / 605 |
| pancreas | 100% | 839.58 | 327 / 328 | 99% | 12.21 | 177 / 178 |
| liver | 100% | 1295.06 | 226 / 226 | 99% | 11.33 | 402 / 406 |
| adrenal gland | 100% | 1150.12 | 258 / 258 | 99% | 18.31 | 227 / 230 |
| bladder | 100% | 1071.71 | 21 / 21 | 99% | 12.23 | 497 / 504 |
| kidney | 100% | 957.75 | 89 / 89 | 98% | 17.24 | 887 / 901 |
| stomach | 100% | 807.03 | 358 / 359 | 98% | 11.85 | 280 / 286 |
| intestine | 100% | 1068.99 | 966 / 966 | 97% | 12.54 | 512 / 527 |
| skin | 99% | 833.14 | 1793 / 1809 | 92% | 16.53 | 436 / 472 |
| blood vessel | 100% | 1161.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.22 | 29 / 29 |
| muscle | 100% | 1120.19 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1302.71 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.08 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.14 | 1 / 1 |
| adipose | 100% | 1038.04 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 865.17 | 850 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 70% | 638.64 | 653 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 59% | 4.73 | 47 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045786 | Biological process | negative regulation of cell cycle |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0002020 | Molecular function | protease binding |
| GO_0003677 | Molecular function | DNA binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | THAP5 |
| Protein name | THAP domain-containing protein 5 |
| Synonyms | |
| Description | FUNCTION: Has sequence-specific DNA-binding activity and can function as transcriptional repressor (in vitro) . May be a regulator of cell cycle: THAP5 overexpression in human cell lines causes cell cycle arrest at G2/M phase . . |
| Accessions | ENST00000313516.5 [Q7Z6K1-2] ENST00000438865.1 ENST00000415914.4 [Q7Z6K1-1] C9JIH7 Q7Z6K1 |
